Mobile

Phase II multi-centre, randomised, open, comparative study of the safety and efficacy of transdermal testosterone (Testim®) compared to intramuscular testosterone depot for the induction of puberty in...

Update Il y a 4 ans
Reference: EUCTR2006-005200-13

Phase II multi-centre, randomised, open, comparative study of the safety and efficacy of transdermal testosterone (Testim®) compared to intramuscular testosterone depot for the induction of puberty in boys with hypogonadism and delayed puberty

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To compare daily transcutaneous therapy with Testim® with the standard therapy with monthly (every four weeks) testosterone depot intramuscular injections with respect to efficacy and safety.

Inclusion criteria

  • Delayed puberty due to central (hypogonadotrophic) or peripheral (hypergonadotrophic) hypogonadism

Links